Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival.

Cancer Manag Res · 2018 · PMC6178934 · PMID 30323673

Europe PMC DOI

hedged sentence

0.0680

closest p · 1.4× alpha

0.0680

boldest claim

The sentences

borderline significanceP =0.068so close (0.05 < p ≤ 0.1)

Correlation of GP88 levels with clinicopathological parameters Serum GP88 level was not different in PSA level groups (<4 ng vs ≥4 ng) or tumor stage groups (T1/2 vs T3/4) but was different with borderline significance in age groups (≤66 years vs >66 years; P =0.068) in nonparametric tests.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.